School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program.
A local general practice was contracted to provide the school-based immunisation program over two years in Mount Isa, Queensland. The schedule was for female Year 10, 11 and 12 students to receive three doses of human papilloma virus (HPV) vaccination (Gardasil). This was provided as part of the broader immunisation program that involved providing Year 8 students with two doses of hepatitis B vaccination and one dose of varicella-zoster, and Year 10 students with one dose of diphtheria-tetanus-pertussis (DTPa). Data were collected on the number of consent forms returned and how many declined vaccination, how many students were vaccinated and those requiring catch-up vaccinations, as well as the total number completing the full course of immunisations. Adverse events were also recorded. The total cohort of girls eligible for HPV vaccination was 304 (consented to vaccination--275 (90%), declined vaccination--13 (4%), coverage for first HPV dose--89%, coverage for second HPV dose--88%, coverage for third HPV dose--79%). When compared with other adolescent vaccinations given concurrently as part of the broader vaccination program, HPV coverage was higher. There were only three significant adverse events. Three girls fainted at the time of immunisation but recovered immediately. The HPV immunisation had a good uptake and was well tolerated. Integrating school immunisation provision with general practice provides continuity with preschool immunisations and provides a convenient location for parents to bring children who have missed out on immunisations or would like to discuss the immunisation program
Reeve
Carole
C
Mount Isa Centre for Rural and Remote Health, Queensland.
De La Rue
Stephanie
S
Pashen
Dennis
D
Culpan
Margaret
M
Cheffins
Tracy
T
D000293:Adolescent; D002648:Child; D005194:Family Practice; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D032541:Mass Vaccination / Q000379:methods*; D030361:Papillomavirus Infections / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000276:immunology*; D033282:Parental Consent / Q000706:statistics & numerical data; D011793:Queensland / Q000453:epidemiology; D012424:Rural Population; D012572:School Health Services
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines